A previous study found that calnexin improved the expression of PD-1 in T-cells by suppressing the DNA methylation state in a PD-1 promoter, and revealed the mechanism by which calnexin in tumor cells regulates the anti-tumor response of T-cells, suggesting that calnexin may be a potential target for improving anti-tumor immunotherapy [85]. Here, CANX is linked to neoplasm.